The Revolutionary Trial That Has Wall Street Racing Back to Moderna
Thanks to some major breakthroughs in healthcare, AI was in the news a lot this week for all the right reasons. Eric Bleeker and Austin Smith break down what this means for companies like Moderna and their investors.







